Roche Holding | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
AbbVie USD 3.29B 562M 2025-03
Alcon AG USD 813M 11M 2025-03
Almirall EUR 146.82M 197.04M 2024-12
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Bayer EUR 3.71B 628M 2025-03
Biogen USD 572.5M 104.8M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Fresenius EUR 643M 126M 2025-03
Fresenius Medical Care EUR 751M 89M 2025-03
Galapagos EUR 43.8M 2.55M 2025-03
Genmab DKK 126M 1.12B 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
GRIFOLS EUR 324.65M 55.17M 2025-03
Hikma Pharmaceutical USD 280M 4M 2024-06
Merck EUR 1.05B 361M 2024-12
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Orion EUR 84.3M 30.6M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Philips EUR 1.25B 77M 2025-03
Recordati EUR 181.39M 32.05M 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
UCB EUR 533M 434M 2024-06



Roche Holding Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.